Local pharmacy’s advice on surviving Loblaws buyout: Specialize!
Local pharmacies will need to specialize even further to stay alive after pharma giants merge, independent owners say
Tag: pharma
National Pharmaceutical Congress will focus on problems in marketing
Next week’s National Pharmaceutical Congress will address problems in pharma marketing
Roche uses Mississauga drug plant to dole out Tamiflu in tough season
Roche needs far more supplies this year than last of its flu treatment as number of cases nationally rises sharply
Drug research companies could benefit from new patent rules, says industry group
As Mississauga’s drug research companies prepare for possible new patent rules under the Canada-EU free trade deal, an industry group says improved intellectual property protection would be a shot in the arm for the city’s pivotal life sciences sector
Mississauga’s YM BioSciences acquired by Gilead for $465M
Mississauga drug development company YM Biosciences announced today it had been acquired by Gilead Sciences Inc. for $465 million
Second company halts business with Chemi after licence suspension
Veterinary pharmaceutical company cuts ties with Mississauga testing lab Chemi Pharmaceutical Inc. after its licence was suspended by Health Canada
Cipher Pharmaceuticals starts launch of new acne drug in U.S.
Mississauga-based drug developer Cipher Pharmaceuticals says its U.S. partner has begun selling and promoting a new drug to treat severe acne
Cipher Pharmaceuticals gets Health Canada approval for new acne drug
Mississauga drug company Cipher Pharmaceuticals Inc. has received Health Canada approved for its new acne drug Epuris
Roche receives Health Canada approval for new test
Drug maker Roche Canada, which employs hundreds at its Mississauga pill-making plant, is getting Health Canada approval for a new test for an infectious virus common in organ transplants
Pill Hill: Biotech drives Mississauga’s economy
Meadowvale’s “Pill Hill” is a cluster of most of the city’s biotechnology, biomedical and other life-science companies
Karen K. Ho 